Case Studies – 1

Reformulated drugs with improved efficacy

NLAB SilicaTM has shown great potential for tackling one of the most pressing global issues of multi resistant bacteria which, according to the World Health Organization (WHO), is a major threat to worldwide public health. Nanologica developed new formulations of marketed anti-infective drugs to overcome complications and limitations of the drugs. The studies demonstrated that the reformulated drugs can lead to improved efficacy and safety compared to the current products. Reformulation of pharmaceutical drugs using NLAB SilicaTM offers an effective route to provide better oral treatment to help combat infectious diseases, such as antibiotic-resistant tuberculosis or HIV.